In the current venture climate, tech for pharma is recession-proof
MedCity News
AUGUST 25, 2022
Specialty drugs reportedly reached 50 percent of all drug spending in 2020, a figure that has increased significantly over the last decade.
Sat.Aug 20, 2022 - Fri.Aug 26, 2022
335 
Patents, pandemics and pricing: a peek at the top drug from every big pharma
PharmaVoice
AUGUST 22, 2022
A look at how the biggest pharma companies in the world and their top-selling drugs fared in the first half of the year.
Join 8,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
What should DTC do?
World of DTC Marketing
AUGUST 23, 2022
Consumers would ask their doctor about an advertised prescription drug in a perfect world. In our REAL world, that isn’t the way it happens. Is there a disconnect between what DTC marketers think will happen and what happens with DTC? The research was straightforward. Ask current patients what drove them to get an Rx for a branded product (MS drug).
A Sales Training Strategies Action Plan to Ignite Your Team’s Success
Integrity Solutions
AUGUST 24, 2022
If you’ve implemented sales training this year, you’re not alone. Studies have shown that upwards of $15 billion is spent annually on sales training in the United States alone. Several thousand dollars per salesperson is spent annually. But the question is, what kind of a return are organizations getting on that huge investment? And are there specific sales training strategies behind that critical investment to help ensure its success and strong ROI?
State of AI in Sales & Marketing 2025
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
Gilead Sciences’ long-acting HIV drug gets European Commission approval
MedCity News
AUGUST 22, 2022
European marketing authorization of the Gilead Sciences drug, Sunlenca, provides a twice-yearly treatment option for HIV patients whose virus has become resistant to multiple therapies. An FDA decision for drug is expected in December.
Sign up to get articles personalized to your interests!
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
More Trending
Half of cancer deaths are preventable
World of DTC Marketing
AUGUST 22, 2022
Globally, nearly half of deaths due to cancer can be attributable to preventable risk factors, including three leading risks of smoking, drinking too much alcohol, or having a high body mass index, a new paper suggests. According to the Lancet “, although some cancer cases are not preventable, governments can work on a population level to support an environment that minimises exposure to known cancer risk factors.
Blister material as a source of nitrosamine impurities
European Pharmaceutical Review
AUGUST 25, 2022
Following numerous recalls, the industry is striving to investigate the causes, sources and ways to mitigate carcinogenic nitrosamine impurities. In a recent paper, published in the International Journal of Pharmaceutics , researchers identified nitrocellulose blister packaging as a potential source of N -nitrosodimethylamine (NDMA) and N -nitrosodiethylamine (NDEA) impurities.
Amazon Care and Care Medical are shutting down. Is it really that big a deal?
MedCity News
AUGUST 24, 2022
This is the second time Amazon has failed to crack the employer market said an industry observer, after the company loudly touted the novelty of its approach. The first was the high-profile dissolution of Haven created as a joint venture between Amazon, JPMorgan Chase and Berkshire Hathaway. But does this latest failure even matter?
With market success at stake, can tech help solve the diversity problem in clinical trials?
PharmaVoice
AUGUST 24, 2022
Diversity in clinical trials isn’t only important for the health of the overall patient population — it can save millions in lost profits.
The Intersection of AI and Sales: Personalization Without Compromise
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
What is pharma’s responsibility for online health information?
World of DTC Marketing
AUGUST 25, 2022
Research has shown that 74% of all U.S. adults use the Internet, and 61% have looked for health or medical information on the Internet. Additionally, 49% have accessed a website that provides information about a specific medical condition or problem. Many people get health information from the Internet but are left on their own to determine if it’s credible.
Long COVID but short on treatment options
pharmaphorum
AUGUST 23, 2022
With COVID-19 vaccines and therapeutics developed in rapid time, Ben Hargreaves investigates why this has not been the case with the creation of a treatment for Long COVID. The condition is more common than might be thought and presents a significant burden to patients, and yet the pipeline of potential therapies remains relatively sparse. When the pandemic first struck, the gravity of the situation did not take long to set in.
Protecting patient data as risk of cyberattacks grows
MedCity News
AUGUST 26, 2022
The healthcare industry is under constant threat from cyberattacks. By adopting the measures identified in this article, healthcare organizations can help to improve their cybersecurity and mitigate risk.
Overcoming mental health’s drug development challenges with AI
PharmaVoice
AUGUST 23, 2022
PsychoGenics is leveraging AI-driven drug discovery platforms to advance mental health treatments for schizophrenia, bipolar disorder and treatment-resistant depression.
AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Magnetic Microrobots Assist with Root Canal Treatment
Medgadget
AUGUST 22, 2022
Researchers at the University of Pennsylvania have developed a microrobot system that can help with biofilm disruption, drug delivery, and sample retrieval, all within the restrictive space of the root canal. It can be difficult for dentists to know if they have removed all the infectious material when performing a root canal, and failure to do so will typically result in an infection reoccurring.
Why You Should Consider Diagnostic Sales With Mac Mckellar
Evolve Your Success
AUGUST 23, 2022
There is more to being a medical sales representative than meets the eye. Just because they sell within the healthcare industry does not mean they can be lumped into one thing. In fact, one little-known field is being a diagnostic testing sales representative. If you haven’t yet encountered someone from this side of medical sales, then you are in luck!
DotCom Therapy expands pediatric healthcare access by accepting Medicaid
MedCity News
AUGUST 26, 2022
Pediatric teletherapy provider DotCom Therapy has been approved to accept Medicaid through Wisconsin’s BadgerCare Plus program. It’s the first Medicaid contract for the company, which has primarily worked with schools and commercial insurers in the past.
First 90 Days: Agios Pharmaceuticals’ Brian Goff
PharmaVoice
AUGUST 22, 2022
The rare disease veteran and first-time CEO is bringing his expertise to the company as it launches the first FDA-approved treatment for pyruvate kinase (PK) deficiency.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
The BIOMEDevice Shows and Why They Matter with Adrienne Zepeda, Group Event Director
Medical Device Success
AUGUST 21, 2022
Reading time: 2 – 3 minutes. Have you ever heard of BIOMEDevice Boston or BIOMEDevice Silicone Valley? These are two of several MedTech Industry shows that are known as hubs of new technologies, startup guidance and networking opportunities. Do you know what goes on at these meetings? I can tell you that they are organized to give MedTech leaders and startups a view into the technologies and best practices that will shape our devices and services for years to come.
Smart Socks Help Prevent Falls Among At-Risk Patients
Medgadget
AUGUST 25, 2022
Researchers at the Ohio State University Wexner Medical Center have tested the PUP (Patient is Up) Smart Socks, developed by a medtech company called Palarum , in their ability to reduce falls among at-risk patients. The socks contain pressure sensors that alert caregivers when a patient is attempting to stand up. This can include situations such as a patient getting out of bed to go to the toilet.
The business of empathy: How pharmacists can improve performance by improving the human connection
MedCity News
AUGUST 26, 2022
When pharmacies engage on a human level with patient support programs, patients become more fully engaged in their treatment, leading to potentially significant health benefits and good business for pharmacies.
Flipping the script to disrupt, redefine and accelerate the patient care journey
PharmaVoice
AUGUST 22, 2022
A new, digitally innovative care model empowers patients and expedites their access to treatment.
The GTM Intelligence Era: ZoomInfo 2025 Customer Impact Report
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
Non-viral CRISPR could overcome cell and gene therapy bottlenecks
European Pharmaceutical Review
AUGUST 26, 2022
Scientists from the Gladstone Institutes and University of California San Francisco (UCSF) say a new variation of the CRISPR-Cas9 gene editing system enables especially long DNA sequences to be introduced to precise locations in the genomes of cells with remarkably high efficiency without the need for viral vectors. “One of our goals for many years has been to put lengthy DNA instructions into a targeted site in the genome in a way that doesn’t depend on viral vectors,” commented Alex Marson, MD
New study use musical tests for early detection of cognitive decline
PharmaTimes
AUGUST 22, 2022
Researchers at Tel Aviv University used a portable brain activity-measuring device to detect cognitive decline in older people
CMS calls on states to tie Medicaid payments to quality measures for nursing homes
MedCity News
AUGUST 25, 2022
States that do this can improve staffing and outcomes for patients in nursing facilities. Some states, like California and Illinois, have already implemented initiatives that incentivize nursing homes through Medicaid payments.
Woman of the Week: Glympse Bio’s Dr. Tram Tran
PharmaVoice
AUGUST 24, 2022
How the chief medical officer of the emerging diagnostic company is using the patient perspective as a guiding light.
AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Sword’s digital musculoskeletal care approach improves mental health; study
pharmaphorum
AUGUST 26, 2022
A clinical trial has found that a digital care programme for people with musculoskeletal pain developed by Sword Health can improve their productivity at work, even if they also have mental health issues. Sword Health’s virtual musculoskeletal programme care programme pairs patients with a physical therapist they can talk with via telehealth, guiding them through exercises to address pain and other symptoms and also provides cognitive behavioural therapy (CBT) modules to help them develop
Jazz Pharmaceuticals’ epilepsy drug advances into phase 3 trial
PharmaTimes
AUGUST 22, 2022
Epidiolex may ease symptoms associated with Doose syndrome, a rarer type of childhood-onset epilepsy
Moderna’s Covid-19 vaccine patent suit points to different virus to make infringement case against Pfizer
MedCity News
AUGUST 26, 2022
Moderna is suing Pfizer and BioNTech, claiming they copied its messenger RNA work in developing their Covid-19 vaccine. The company notes that its patented work in respiratory infectious disease began years before the start of the Covid-19 pandemic, when the biotech was pursuing an mRNA vaccine for a different coronavirus.
Let's personalize your content